Sweden· SE-19880617000024
Megace 160 mg Tablett
A medicinal product containing megestrol acetate, registered in Sweden by Bausch Health Ireland Ltd.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Megestrol Acetate
- Manufacturer
- Bausch Health Ireland Ltd
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19880617000024
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Megestrol acetate in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMegace 160mg tabletsDowelhurst Ltd
- CzechiaMEGACEBausch Health Ireland Limited, Dublin
- ItalyGESTROLTEXISTITUTO GENTILI S.R.L.
- IrelandMegace 160 mg tabletsBausch Health Ireland Limited
- NorwayMegaceBausch Health Ireland Limited
- SpainBOREA 160 mg COMPRIMIDOSViatris Healthcare Limited
- FranceMEGACE 160 mg, compriméBAUSCH HEALTH IRELAND (IRLANDE)
- FinlandMegaceBristol-Myers Squibb Ab
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Belgium · Megace
- Cyprus · Megace
- Czechia · Megace, Megaplex
- Germany · Megestat
- Spain · Borea, Maygace Altas Dosis
- France · Megace
- United Kingdom (Northern Ireland) · Megace
- Greece · Megace
- Croatia · Megace, Megostat
- Hungary · Cachexi, Megace
- Ireland · Megace
- Italy · Gestroltex, Megace
- Lithuania · Megace
- Luxembourg · Megace
- Netherlands · Megestrolacetaat Focus
- Norway · Megace
- Poland · Cachexan, Megace
- Portugal · Megace, Megestrol Generis
- Romania · Megesin
- Slovenia · Megace
- Slovakia · Megesin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a87842e6-534f-4d7d-929b-3973732ad650 GET /v1/drugs/a87842e6-534f-4d7d-929b-3973732ad650?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "19880617000024",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19880617000024",
"product_doc_link": "https://docetp.mpa.se/LMF/Megace%20tablet%20SmPC_09001bee807a4990.pdf"
}See everything about megestrol acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.